Edition:
United States

People: Mesoblast Ltd (MSB.AX)

MSB.AX on Australia Stock Exchange

1.20AUD
8:09pm EST
Change (% chg)

$-0.03 (-2.05%)
Prev Close
$1.22
Open
$1.22
Day's High
$1.22
Day's Low
$1.19
Volume
160,957
Avg. Vol
817,808
52-wk High
$3.03
52-wk Low
$1.01

O'Dwyer, Donal 

Mr. Donal P. O'Dwyer is Non-Executive Independent Director of Mesoblast Ltd. He has over 25 years of experience as a senior executive in the global cardiovascular and medical devices industries. From 1996 to 2003, Mr O’Dwyer worked for Cordis Cardiology, the cardiology division of Johnson & Johnson’s Cordis Corporation, initially as its president (Europe) and from 2000 as its worldwide president. Prior to joining Cordis, he worked for 12 years with Baxter Healthcare, rising from plant manager in Ireland to president of the Cardiovascular Group, Europe, now Edwards Lifesciences. He is a qualified civil engineer, has a MBA and is on the Board of Directors of a number of life sciences companies including Cochlear Limited, Atcor Medical Holdings Ltd and Fisher & Paykel Healthcare Ltd.

Basic Compensation

Total Annual Compensation, AUD 160,750
Restricted Stock Awards, AUD --
Long-Term Incentive Plans, AUD --
All Other, AUD 15,271
Fiscal Year Total, AUD 176,021

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Brian Jamieson

347,103

Silviu Itescu

1,920,910

William Burns

172,077

Paul Hodgkinson

905,196

Charlie Harrison

--

Donal O'Dwyer

176,021
As Of  29 Jun 2015